University of Wyoming, Department of Psychology, Dept. 3415, 1000 E. University Ave., Laramie, WY 82071, USA.
William S. Middleton Memorial Veterans Hospital, 2500 Overlook Terrace, Madison, WI 53705, USA.
Behav Res Ther. 2014 May;56:47-52. doi: 10.1016/j.brat.2014.02.009. Epub 2014 Mar 6.
Although the chemical imbalance theory is the dominant causal explanation of depression in the United States, little is known about the effects of this explanation on depressed individuals. This experiment examined the impact of chemical imbalance test feedback on perceptions of stigma, prognosis, negative mood regulation expectancies, and treatment credibility and expectancy. Participants endorsing a past or current depressive episode received results of a bogus but credible biological test demonstrating their depressive symptoms to be caused, or not caused, by a chemical imbalance in the brain. Results showed that chemical imbalance test feedback failed to reduce self-blame, elicited worse prognostic pessimism and negative mood regulation expectancies, and led participants to view pharmacotherapy as more credible and effective than psychotherapy. The present findings add to a growing literature highlighting the unhelpful and potentially iatrogenic effects of attributing depressive symptoms to a chemical imbalance. Clinical and societal implications of these findings are discussed.
尽管化学失衡理论是美国主导的抑郁症因果解释,但对于这种解释对抑郁个体的影响知之甚少。本实验研究了化学失衡测试反馈对耻辱感、预后、消极情绪调节预期以及治疗可信度和预期的影响。有过去或当前抑郁发作经历的参与者收到了虚假但可信的生物测试结果,表明他们的抑郁症状是由大脑中的化学失衡引起的,或者不是由大脑中的化学失衡引起的。结果表明,化学失衡测试反馈未能减轻自责感,引起更悲观的预后和消极的情绪调节预期,并使参与者认为药物治疗比心理治疗更可信和有效。本研究结果增加了越来越多的文献,这些文献强调了将抑郁症状归因于化学失衡的无益和潜在的医源性影响。讨论了这些发现对临床和社会的意义。